Shareholder alert: levi & korsinsky, llp notifies investors of an investigation into the fairness of the merger of adamas pharmaceuticals, inc. with supernus pharmaceuticals, inc.

New york, new york--(newsfile corp. - october 11, 2021) - the following statement is being issued by levi & korsinsky, llp:to: all persons or entities who purchased adamas pharmaceuticals, inc. (nasdaq: adms) ("adamas" or the "company") stock prior to october 11, 2021. to view an enhanced version of this graphic, please visit:
ADMS Ratings Summary
ADMS Quant Ranking